{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T19:41:37Z","timestamp":1787254897055,"version":"build-2736575974"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1993,12,1]],"date-time":"1993-12-01T00:00:00Z","timestamp":754704000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[1993,12]]},"DOI":"10.1007\/bf02245706","type":"journal-article","created":{"date-parts":[[2005,11,15]],"date-time":"2005-11-15T01:51:13Z","timestamp":1132019473000},"page":"250-256","source":"Crossref","is-referenced-by-count":23,"title":["Effect of clozapine upon schedule-induced polydipsia (SIP) resembles neither the actions of dopamine D1 nor D2 blockade"],"prefix":"10.1007","volume":"113","author":[{"given":"Michael","family":"Didriksen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar M.","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Vibeke","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"suppl. 17","key":"BF02245706_CR1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1192\/S0007125000296852","volume":"160","author":"RJ Baldessarini","year":"1992","unstructured":"Baldessarini RJ, Huston-Lyons D, Campbell A, Marsh E, Cohen BM (1992) Do central antiadrenergic actions contribute to the atypical properties of clozapine? Br J Psychiatry 160[suppl. 17]:12\u201316","journal-title":"Br J Psychiatry"},{"issue":"2","key":"BF02245706_CR2","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1176\/ajp.135.2.164","volume":"135","author":"A Carlsson","year":"1978","unstructured":"Carlsson A (1978) Antipsychotic drugs, neurotransmitters, and schizophrenia. Am J Psychiatry 135[2]:164\u2013173","journal-title":"Am J Psychiatry"},{"issue":"8","key":"BF02245706_CR3","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1523\/JNEUROSCI.03-08-01607.1983","volume":"3","author":"LA Chiodo","year":"1983","unstructured":"Chiodo LA, Bunney BS (1983) Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons. J Neurosci 3[8]:1607\u20131619","journal-title":"J Neurosci"},{"key":"BF02245706_CR4","first-page":"49","volume":"3","author":"AV Christensen","year":"1990","unstructured":"Christensen AV (1990) Long-term effects of dopamine D-1 and D-2 antagonists in Vervet monkeys. Behav Neurol 3:49\u201360","journal-title":"Behav Neurol"},{"key":"BF02245706_CR5","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/978-3-642-70140-5_22","volume-title":"Dyskinesia, research and treatment, Psychopharmacology supplementum 2","author":"AV Christensen","year":"1985","unstructured":"Christensen AV, Arnt J, Svendsen O (1985) Pharmacological differentiation of dopamine D-1 and D-2 antagonists after single and repeated administration. In: Casey DE, Chase TN, Christensen AV, Gerlach J (eds) Dyskinesia, research and treatment, Psychopharmacology supplementum 2. Springer, Berlin Heidelberg, pp 182\u2013190"},{"issue":"3","key":"BF02245706_CR6","first-page":"769","volume":"249","author":"VL Coffin","year":"1989","unstructured":"Coffin VL, Latranyi MB, Chipkin RE (1989) Acute extrapyramidal syndrome in cebus monkeys: development mediated by dopamine D2 but not D1 receptors. J Pharmacol Exp Ther 249[3]:769\u2013774","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02245706_CR7","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1055\/s-2007-1017171","volume":"19","author":"A Delini-Stula","year":"1986","unstructured":"Delini-Stula A (1986) Neuroanatomical, neuropharmacological and neurobiochemical target systems for antipsychotic activity of neuroleptics. Pharmacopsychiatry 19:134\u2013139","journal-title":"Pharmacopsychiatry"},{"key":"BF02245706_CR8","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1126\/science.133.3447.195","volume":"133","author":"JL Falk","year":"1961","unstructured":"Falk JL (1961) Production of polydipsia in normal rats by an intermittent food schedule. Science 133:195\u2013196","journal-title":"Science"},{"key":"BF02245706_CR9","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/0031-9384(71)90209-5","volume":"6","author":"JL Falk","year":"1971","unstructured":"Falk JL (1971) Theoretical review. The nature and determinants of adjunctive behaviour. Physiol Behav 6:577\u2013588","journal-title":"Physiol Behav"},{"key":"BF02245706_CR10","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/BF00442555","volume":"99","author":"L Farde","year":"1989","unstructured":"Farde L, Wiesel FA, Nordstr\u00f6m A-L, Sedvall G (1989) D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics. Psychopharmacology 99:28\u201331","journal-title":"Psychopharmacology"},{"issue":"5","key":"BF02245706_CR11","doi-asserted-by":"crossref","first-page":"722","DOI":"10.2165\/00003495-199040050-00007","volume":"40","author":"A Fitton","year":"1990","unstructured":"Fitton A, Heel RC (1990) Clozapine, a review of its pharmacological properties, and therapeutic use in schizophrenia. Drugs 40[5]:722\u2013747","journal-title":"Drugs"},{"key":"BF02245706_CR12","first-page":"47","volume":"24","author":"J Gerlach","year":"1991","unstructured":"Gerlach J (1991) Current views on tardive dyskinesia. Pharmacopsychiatry 24:47\u201348","journal-title":"Pharmacopsychiatry"},{"key":"BF02245706_CR13","first-page":"406","volume":"11","author":"J Hietala","year":"1990","unstructured":"Hietala J, Lappalainen J, Koulu M, Syv\u00e4lathi E (1990) Dopamine D1 receptor antagonism in schizophrenia: is there reduced risk of extrapyramidal side-effects? TIPS 11:406\u2013410","journal-title":"TIPS"},{"key":"BF02245706_CR14","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0014-2999(83)90381-3","volume":"91","author":"J Hyttel","year":"1983","unstructured":"Hyttel J (1983) SCH 23390 \u2014 the first selective dopamine D-1 antagonist. Eur J Pharmacol 91:153\u2013154","journal-title":"Eur J Pharmacol"},{"key":"BF02245706_CR15","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF02098496","volume":"68","author":"J Hyttel","year":"1987","unstructured":"Hyttel J, Arnt J (1987) Characterization of binding of3H-SCH 23390 to dopamine D-1 receptors. Correlation to other D-1 and D-2 measures and effect of selective lesions. J Neural Transm 68:171\u2013189","journal-title":"J Neural Transm"},{"key":"BF02245706_CR16","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0014-2999(87)90672-8","volume":"142","author":"A Imperato","year":"1987","unstructured":"Imperato A, Mulas A, Di Chiara G (1987) The D-1 antagonist SCH 23390 stimulates while the D-1 agonist SKF 38393 fails to affect dopamine release in the dorsal caudate of freely moving rats. Eur J Pharmacol 142:177\u2013181","journal-title":"Eur J Pharmacol"},{"key":"BF02245706_CR17","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1600-0447.1988.tb05164.x","volume":"77","author":"LH Lindstr\u00f6m","year":"1988","unstructured":"Lindstr\u00f6m LH (1988) The effect of long-term treatment with clozapine in schizophrenia: a retrospective study in 96 patients treated with clozapine for up to 13 years. Acta Psychiatr Scand 77:524\u2013529","journal-title":"Acta Psychiatr Scand"},{"key":"BF02245706_CR18","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1600-0773.1989.tb01117.x","volume":"65","author":"T Ljungberg","year":"1989","unstructured":"Ljungberg T (1989a) Attenuation of water intake and operant responding by dopamine D2 antagonists: raclopride provides important cues for understanding the functional mechanism of action. Pharmacol Toxicol 65:9\u201312","journal-title":"Pharmacol Toxicol"},{"key":"BF02245706_CR19","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/0091-3057(89)90412-7","volume":"33","author":"T Ljungberg","year":"1989","unstructured":"Ljungberg T (1989b) Effects of the dopamine D-1 antagonist SCH 23390 on water intake, water-rewarded operant responding and apomorphine-induced decrease of water intake in rats. Pharmacol Biochem Behav 33:709\u2013712","journal-title":"Pharmacol Biochem Behav"},{"key":"BF02245706_CR20","volume-title":"Advances in neuropsychiatry and psychopharmacology, Vol. 1: Schizophrenia research","author":"HY Meltzer","year":"1991","unstructured":"Meltzer HY (1991) Dopaminergic and serotonergic mechanisms in the action of clozapine. In: Tamminga CA, Schulz SC (eds) Advances in neuropsychiatry and psychopharmacology, Vol. 1: Schizophrenia research. Raven, New York"},{"key":"BF02245706_CR21","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1055\/s-2007-1014437","volume":"24","author":"HY Meltzer","year":"1991","unstructured":"Meltzer HY, Alphs LD, Bastani B, Ramirez LF, Kwon K (1991) Clinical efficacy of clozapine in the treatment of schizophrenia. Pharmacopsychiatry 24:44\u201345","journal-title":"Pharmacopsychiatry"},{"key":"BF02245706_CR22","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/0006-8993(85)90366-X","volume":"348","author":"G Mittleman","year":"1985","unstructured":"Mittleman G, Valenstein ES (1985) Individual differences in non-regulatory ingestive behaviour and catecholamine systems. Brain Res 348:112\u2013117","journal-title":"Brain Res"},{"key":"BF02245706_CR23","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0166-4328(88)90134-9","volume":"28","author":"G Mittleman","year":"1988","unstructured":"Mittleman G, Jones GH, Robbins TW (1988) The relationship between schedule-induced polydipsia and pituitary-adrenal activity: pharmacological and behavioural manipulations. Behav Brain Res 28:315\u2013324","journal-title":"Behav Brain Res"},{"issue":"3","key":"BF02245706_CR24","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1037\/0735-7044.104.3.399","volume":"104","author":"G Mittleman","year":"1990","unstructured":"Mittleman G, Jones GH, Whishaw IQ, Koch M, Robbins TW (1990) Cortical, hippocampal, and striatal mediation of schedule-induced behaviours. Behav Neurosci 104[3]:399\u2013409","journal-title":"Behav Neurosci"},{"key":"BF02245706_CR25","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/BF00179179","volume":"90","author":"SO \u00d6gren","year":"1986","unstructured":"\u00d6gren SO, Hall H, K\u00f6hler C, Magnusson O, Sj\u00f6strand SE (1986) The selective dopamine D2 receptor antagonist raclopride discriminates between dopamine-mediated motor functions. Psychopharmacology 90:287\u2013294","journal-title":"Psychopharmacology"},{"key":"BF02245706_CR26","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3758\/BF03327203","volume":"12","author":"JH Porter","year":"1984","unstructured":"Porter JH, McDonough JJ, Heather GF, Goldsmith PA, Johnson DN (1984) Differential effects of dopamine blockers on the acquisition of schedule-induced drinking and deprivation-induced drinking. Physiol Psychol 12:302\u2013306","journal-title":"Physiol Psychol"},{"issue":"5764","key":"BF02245706_CR27","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/285409a0","volume":"285","author":"TW Robbins","year":"1980","unstructured":"Robbins TW, Koob GF (1980) Selective disruption of displacement behaviour by lesions of the mesolimbic dopamine system. Nature 285[5764]:409\u2013412","journal-title":"Nature"},{"issue":"3","key":"BF02245706_CR28","first-page":"662","volume":"224","author":"TW Robbins","year":"1983","unstructured":"Robbins TW, Roberts DCS, Koob GF (1983) Effects ofd-amphetamine and apomorphine upon operant behaviour and schedule-induced licking in rats with 6-hydroxydopamine-induced lesions of the nucleus accumbens. J Pharmacol Exp Ther 224[3]:662\u2013673","journal-title":"J Pharmacol Exp Ther"},{"issue":"suppl.358","key":"BF02245706_CR29","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1600-0447.1990.tb05280.x","volume":"82","author":"P Seeman","year":"1990","unstructured":"Seeman P (1990) Atypical neuroleptics: role of multiple receptors, endogenous dopamine, and receptor linkage. Acta Psychiatr Scand 82[suppl.358]:14\u201320","journal-title":"Acta Psychiatr Scand"},{"key":"BF02245706_CR30","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/0024-3205(88)90558-9","volume":"42","author":"T Skarsfeldt","year":"1988","unstructured":"Skarsfeldt T (1988) Differential effects after repeated treatment with haloperidol, clozapine, thioridazine and tefludazine on SNC and VTA dopamine neurons in rats. Life Sci 42:1037\u20131044","journal-title":"Life Sci"},{"key":"BF02245706_CR31","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0091-3057(92)90130-8","volume":"42","author":"KG Todd","year":"1992","unstructured":"Todd KG, Beck CHM, Martin-Iverson MT (1992) Effects of D1 and D2 dopamine antagonists on behavior of polydipsic rats. Pharmacol Biochem Behav 42:381\u2013388","journal-title":"Pharmacol Biochem Behav"},{"key":"BF02245706_CR32","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/350610a0","volume":"350","author":"HHM Tol Van","year":"1991","unstructured":"Van Tol HHM, Bunzow JR, Guan H-C, Sunahara RK, Seeman P, Niznik BH, Civelli O (1991) Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature 350:610\u2013614","journal-title":"Nature"},{"key":"BF02245706_CR33","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0091-3057(83)90262-9","volume":"18","author":"M Wallace","year":"1983","unstructured":"Wallace M, Singer G, Finlay J. Gibson S (1983) The effect of 6-OHDA lesions of the nucleus accumbens septum on schedule-induced drinking, wheelrunning and corticosterone levels in the rat. Pharmacol Biochem Behav 18:129\u2013136","journal-title":"Pharmacol Biochem Behav"},{"key":"BF02245706_CR34","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1126\/science.6136093","volume":"221","author":"FJ White","year":"1983","unstructured":"White FJ, Wang RY (1983) Differential effects of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurons. Science 221:1054\u20131057","journal-title":"Science"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02245706.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02245706\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02245706","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T22:09:30Z","timestamp":1586556570000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02245706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,12]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1993,12]]}},"alternative-id":["BF02245706"],"URL":"https:\/\/doi.org\/10.1007\/bf02245706","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,12]]}}}